Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) provided a development update for ZYN001 and ZYN002.Zynerba and its development partner, LTS LOHMANN Therapie-Systeme ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE